Recent work in Psychedelics
Learn more about how uMotif is supporting complex trials that explore the impact of psychedelics on CNS conditions.
We are dedicated to supporting complex trials aimed at understanding the impact of psychedelics on CNS conditions, providing essential tools and expertise to navigate this innovative field effectively.
Psychedelics in the treatment of Major Depressive Disorder
- Phase 3 study
- Patient captured ePROs at home and site visits
- Centrally rated capture of ClinROs including SIGMA/MADRS, with audio recording
- Hybrid study design with on site and remote assessments
- Central review with real-time access to assessments and recordings
Psilocybin for the treatment of Generalized Anxiety Disorder
- Phase 2a study
- Suite of ClinRO assessments captured at site, including C-SSRS
- Home and site based patient captured ePROs
- Remote Telehealth to support study journey
- Real-time data reports for sites and sponsor
